These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4470322)

  • 1. [Effects of L-DOPA on the physiological nocturnal sleep of patients with facial paraspasm].
    Di Perri R; Di Rosa AE; Leggiadro N; Meduri M
    Acta Neurol (Napoli); 1974; 29(6):675-80. PubMed ID: 4470322
    [No Abstract]   [Full Text] [Related]  

  • 2. [Polygraphic analysis of nocturnal sleep in subjects affected by bilateral facial spasm, prior to and following L-DOPA administration (author's transl)].
    Di Perri R; Di Rosa AE; Meduri M; Messina C
    Riv Patol Nerv Ment; 1974 Oct; 95(5):662-72. PubMed ID: 4470266
    [No Abstract]   [Full Text] [Related]  

  • 3. L-DOPA/carbidopa for nocturnal movement disorders in uremia.
    Walker SL; Fine A; Kryger MH
    Sleep; 1996 Apr; 19(3):214-8. PubMed ID: 8723378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodic leg movement, L-dopa, 5-hydroxytryptophan, and L-tryptophan.
    Guilleminault C; Mondini S; Montplaisir J; Mancuso J; Cobasko D; Dement WC
    Sleep; 1987 Aug; 10(4):393-7. PubMed ID: 3659737
    [No Abstract]   [Full Text] [Related]  

  • 5. Decreased phasic EMG activity during rapid eye movement sleep in treatment-naïve Parkinson's disease: effects of treatment with levodopa and progression of illness.
    Garcia-Borreguero D; Caminero AB; De La Llave Y; Larrosa O; Barrio S; Granizo JJ; Pareja JA
    Mov Disord; 2002 Sep; 17(5):934-41. PubMed ID: 12360542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of levodopa on nocturnal penile tumescence: a preliminary study.
    Horita H; Sato Y; Adachi H; Suzuki N; Kato R; Hisasue S; Suzuki K; Tsukamoto T
    J Androl; 1998; 19(5):619-24. PubMed ID: 9796623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavior of facial paraspasm during various phases of physiological nocturnal sleep].
    Di Perri R; Di Rosa AE; Meduri M; Messina C
    Riv Neurol; 1975; 45(3):305-12. PubMed ID: 180588
    [No Abstract]   [Full Text] [Related]  

  • 8. [L-dopa-responsive dystonia: 2 familial cases of adult onset with sleep disorders].
    el Alaoui-Faris M; Ouahabi H; Nadifi M; Chkili T
    Rev Neurol (Paris); 1995 May; 151(5):347-9. PubMed ID: 7481395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome.
    Garcia-Borreguero D; Larrosa O; Granizo JJ; de la Llave Y; Hening WA
    Sleep; 2004 Jun; 27(4):669-73. PubMed ID: 15283001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Narcolepsy: REM sleep suppression by L-dopa.
    Gilbert JC; Willer JC; Bernheim-Chaltelain C; Ecoffet M; Jaillon P
    N Engl J Med; 1976 Apr; 294(15):849. PubMed ID: 175275
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of dopaminergic substances on sleep/wakefulness in saline- and MPTP-treated mice.
    Laloux C; Derambure P; Houdayer E; Jacquesson JM; Bordet R; Destée A; Monaca C
    J Sleep Res; 2008 Mar; 17(1):101-10. PubMed ID: 18275560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Night sleep in facial hemispasm and paraspasm].
    Arzumanian AM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(10):62-6. PubMed ID: 2618234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new levodopa benserazide preparation for Parkinson's disease with motor fluctuations refractory to standard L-dopa].
    Fernández Pardal MM; Gatto E; Micheli F; Casas Parera I; Diaz S
    Medicina (B Aires); 1991; 51(6):561-7. PubMed ID: 7476112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of facial hemispasm using Tegretol].
    Pechan J
    Med Welt; 1972 Mar; 23(11):384-7. PubMed ID: 5040392
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey].
    Bailbé M; Karolewicz S; Neau JP; Dumas P; Gil R;
    Rev Neurol (Paris); 2002 Feb; 158(2):203-10. PubMed ID: 11965176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial tics in children: the therapeutic effect of low-dosage diazepam.
    Frederiks JA
    Br J Clin Pract; 1970 Jan; 24(1):17-20. PubMed ID: 5413488
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon.
    Uchiyama T; Sakakibara R; Hattori T; Yamanishi T
    Mov Disord; 2003 May; 18(5):573-8. PubMed ID: 12722172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of primary facial spasm].
    Wang SZ
    Zhonghua Kou Qiang Ke Za Zhi; 1980 Dec; 15(4):249-51. PubMed ID: 6943004
    [No Abstract]   [Full Text] [Related]  

  • 19. Sleep benefit in Parkinson's disease.
    Merello M; Hughes A; Colosimo C; Hoffman M; Starkstein S; Leiguarda R
    Mov Disord; 1997 Jul; 12(4):506-8. PubMed ID: 9251067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleepiness in Parkinson's disease: a controlled study.
    Brodsky MA; Godbold J; Roth T; Olanow CW
    Mov Disord; 2003 Jun; 18(6):668-72. PubMed ID: 12784270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.